Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation

B Long, BM Carius, S Chavez, SY Liang… - The American journal of …, 2022 - Elsevier
Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection

SH Safiabadi Tali, JJ LeBlanc, Z Sadiq… - Clinical microbiology …, 2021 - Am Soc Microbiol
SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

[LIVRE][B] Cochrane handbook for systematic reviews of diagnostic test accuracy

JJ Deeks, PM Bossuyt, MM Leeflang, Y Takwoingi - 2023 - books.google.com
Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy A guide to
conducting systematic reviews of test accuracy In Cochrane Handbook for Systematic …

Rapid diagnostic testing for SARS-CoV-2

PK Drain - New England journal of medicine, 2022 - Mass Medical Soc
Key Clinical Points Rapid Diagnostic Testing for SARS-CoV-2 Rapid diagnostic tests (RDTs)
that are authorized by the Food and Drug Administration to diagnose severe acute …

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19

T Struyf, JJ Deeks, J Dinnes… - Cochrane database …, 2022 - cochranelibrary.com
Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …

Ten years of lateral flow immunoassay technique applications: Trends, challenges and future perspectives

F Di Nardo, M Chiarello, S Cavalera, C Baggiani… - Sensors, 2021 - mdpi.com
The Lateral Flow Immunoassay (LFIA) is by far one of the most successful analytical
platforms to perform the on-site detection of target substances. LFIA can be considered as a …

Lateral flow test engineering and lessons learned from COVID-19

J Budd, BS Miller, NE Weckman, D Cherkaoui… - Nature Reviews …, 2023 - nature.com
The acceptability and feasibility of large-scale testing with lateral flow tests (LFTs) for clinical
and public health purposes has been demonstrated during the COVID-19 pandemic. LFTs …

Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis

LE Brümmer, S Katzenschlager, M Gaeddert… - PLoS …, 2021 - journals.plos.org
Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being
integrated in testing strategies around the world. Studies of the Ag-RDTs have shown …

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European …

S Cesaro, P Ljungman, M Mikulska, HH Hirsch… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …